购物车
- 全部删除
- 您的购物车当前为空
TOPOI/PARP-1-IN-2 (compound 6c) 作为一种针对PARP-1和拓扑异构酶1 (TOPO-1) 的双重抑制剂,其IC50值分别为32.2 nM与46.2 nM。该化合物在抑制PARP-1的活性上,相较于PARP-2展现出更高的选择性。此外,TOPOI/PARP-1-IN-2 能够干扰S期的细胞周期并在NCI-60癌细胞系中引发细胞凋亡 (apoptosis)。
TOPOI/PARP-1-IN-2 (compound 6c) 作为一种针对PARP-1和拓扑异构酶1 (TOPO-1) 的双重抑制剂,其IC50值分别为32.2 nM与46.2 nM。该化合物在抑制PARP-1的活性上,相较于PARP-2展现出更高的选择性。此外,TOPOI/PARP-1-IN-2 能够干扰S期的细胞周期并在NCI-60癌细胞系中引发细胞凋亡 (apoptosis)。
产品描述 | TOPOI/PARP-1-IN-2 (compound 6c) serves as a dual inhibitor targeting both PARP-1 and topoisomerase 1 (TOPO-1), with IC50 values of 32.2 nM and 46.2 nM, respectively. This compound exhibits greater selectivity for PARP-1 over PARP-2. Additionally, TOPOI/PARP-1-IN-2 disrupts the S phase of the cell cycle and induces apoptosis in the NCI-60 cancer cell lines. |
靶点活性 | PARP2:2844 nM, Topo I:46.2 nM, PARP1:32.2 nM |
分子量 | 465.95 |
分子式 | C20H27ClN2NaO5S |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容